https://www.streetwisereports.com/article/2025/10/28/price-target-on-psychiatric-drug-biotech-boosted-200.html
Alto Neuroscience Inc. (ANRO:NYSE) completed a US$50 million equity raise and announced plans to accelerate development of its recently acquired asset in...
psychiatric drugpricetargetbiotechboosted
https://www.sciencedaily.com/releases/2017/10/171019142910.htm
One way or another, many psychiatric drugs work by binding to receptor molecules in the brain that are sensitive to the neurotransmitter dopamine, a chemical...
psychiatric drugkeytargetcomesfocus